Can Zydus Cadila's Cut-Price Enzalutamide Shake Up Indian Market?

Nearly 90% Discount To Astellas/Pfizer’s Xtandi

 
• By Vibha Ravi
  
Cost effective check approval sign concept illustration design graphic
Cadila's Generic Enzalutamide Shakes Up Current Pricing • Source: Shutterstock

More from Business

More from Scrip